ArticleAmerican journal of cancer research2026
Prognostic value of salt-inducible kinase 2 expression in advanced hepatocellular carcinoma treated with sorafenib or lenvatinib: a propensity score-matched cohort study.
Qinghai Fu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.